Award details

Non-coding elements of the PrP gene and TSE susceptibility

ReferenceBBS/E/I/00000814
Principal Investigator / Supervisor Professor Jean Manson
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 57,330
StatusCompleted
TypeInstitute Project
Start date 01/04/2000
End date 31/08/2001
Duration17 months

Abstract

In order to establish if PrP gene expression is involved in TSE susceptibility it is first necessary to determine which sequences in the PrP drive expression of the gene. We are aiming to define these sequences for both mouse and human PrP. The analysis will be carried out both in vitro through the use of reporter gene constructs and in vivo by producing mice transgenic for a reporter gene under control of PrP sequences. This analysis will allow the sequences responsible for temporal and tissue specificity of PrP gene expression to be established Having defined the sequences which drive PrP gene expression, these sequences will be examined for polymorphisms. The level of PrP gene expression associated with polymorphic sequences will be examined to establish if the polymorphic sequences are associated with different expression levels of PrP. In addition a study will be carried out using CJD patients and controls to establish if any polymorphic sequences are associated with TSE disease susceptibility.

Summary

unavailable
Committee Closed Committee - Agri-food (AF)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file